PG
FMI

PEAK6 Group’s Foundation Medicine, Inc. FMI Stock Holding History

PEAK6 Group’s Portfolio FMI Stock Details FMI Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2018
Q1 		– Sell
-25,800
Closed -$1.76M – 5308
2017
Q4 		$1.76M Buy
+25,800
New +$1.34M 0.01% 1491
2016
Q4 		– Sell
-1,800
Closed -$42K – 5336
2016
Q3 		$42K Buy
+1,800
New +$40.9K ﹤0.01% 3947
2016
Q2 		– Sell
-15,500
Closed -$282K – 5086
2016
Q1 		$282K Sell
15,500
-9,500
-38% -$153K ﹤0.01% 2820
2015
Q4 		$527K Sell
25,000
-5,000
-17% -$96.4K ﹤0.01% 2527
2015
Q3 		$554K Buy
30,000
+15,000
+100% +$375K ﹤0.01% 2793
2015
Q2 		$508K Buy
15,000
+14,800
+7,400% +$595K ﹤0.01% 2745
2015
Q1 		$10K Sell
200
-13,300
-99% -$603K ﹤0.01% 4581
2014
Q4 		$300K Buy
+13,500
New +$312K ﹤0.01% 3028

Other funds holding FMI

GGHC
Gilder Gagnon Howe & Co New York $8.34B AUM 46.58% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Chevy Chase Trust
Chevy Chase Trust Bethesda, Maryland $34.7B AUM 29.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
OC
Oppenheimer & Co New York $8.21B AUM 28.81% 1-Year Est. Return
Lord, Abbett & Co
Lord, Abbett & Co Jersey City, New Jersey $30.6B AUM 57.44% 1-Year Est. Return
CC
Casdin Capital New York $1.32B AUM 76.62% 1-Year Est. Return
HCM
Hitchwood Capital Management New York $184M AUM 3.18% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return

PEAK6 Group's FMI Position: Q1 2017 in Review

PEAK6 Group sold out of Foundation Medicine, Inc. (FMI) in Q1 2017, closing a stake of 5,731 shares — an estimated $101K sold.

PEAK6 Group first reported a position in FMI in Q4 2013 and held it in 8 quarters. The position peaked at $9.44M in Q4 2013. 93 funds tracked by Wall St. Rank hold FMI as of Q1 2017.

  • PEAK6 Group reported no remaining Foundation Medicine, Inc. position as of Q1 2017 after selling out during the quarter.
  • PEAK6 Group sold 5,731 Foundation Medicine, Inc. shares in Q1 2017, an estimated $101K.
  • PEAK6 Group first reported a position in Foundation Medicine, Inc. in Q4 2013 and held it in 8 quarters.
  • PEAK6 Group's Foundation Medicine, Inc. position peaked at $9.44M in Q4 2013.
  • 93 funds tracked by Wall St. Rank held Foundation Medicine, Inc. as of Q1 2017.

Based on PEAK6 Group's 13F filing for Q1 2017, filed 15 May 2017.